Home / Weitere News / Science

Science

Preclinical studies demonstrated that NicA2 reduces nicotine levels in blood and brain, and extinguishes nicotine self-administration in rats. Results support further investigation of optimized variants of NicA2 to treat addiction to nicotine and reduce its adverse health effects.

More on euroinvestor.com